Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer

Clinical trial NCT03878849 · RECRUITING

Trial details

NCT number: NCT03878849
Sponsor: Allarity Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Ovarian Cancer

Start date: 2019-04-15
Primary completion: 2027-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.